Literature DB >> 2360966

In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.

A M Hirschl1, D Wolf, J Berger, M L Rotter.   

Abstract

More than 200 strains of Campylobacter (C.) jejuni/coli isolated in 1985 and 1987/88 from human fecal specimens were tested for their susceptibility to erythromycin and ciprofloxacin. Their MIC90 as assessed by agar dilution tests was 2.0 and 0.5 mg/l, respectively. Thus, all strains were regarded as susceptible to ciprofloxacin. With 2 out of 55 strains of C. coli the MIC of erythromycin was 8.0 mg/l. Therefore, only 3.6% of the C. coli strains were resistant to erythromycin. All 209 strains of C. jejuni proved to be susceptible to erythromycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360966     DOI: 10.1016/s0934-8840(11)80045-9

Source DB:  PubMed          Journal:  Zentralbl Bakteriol        ISSN: 0934-8840


  9 in total

1.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.

Authors:  M A Slavin; I Jennens; W Tee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

Review 3.  The epidemiology of bacterial resistance to quinolones.

Authors:  J F Acar; T F O'Brien; F W Goldstein; R N Jones
Journal:  Drugs       Date:  1993       Impact factor: 9.546

4.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

5.  Campylobacteriosis in Austria: situation and trends.

Authors:  Gebhard Feierl; Sandra Jelovcan
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics.

Authors:  H P Endtz; M Broeren; R P Mouton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

7.  Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

Authors:  H Adler-Mosca; J Lüthy-Hottenstein; G Martinetti Lucchini; A Burnens; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

8.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 9.  Epidemiology of quinolone resistance: Europe and North and South America.

Authors:  F W Goldstein; J F Acar
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.